Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-22-088034
Filing Date
2022-08-09
Accepted
2022-08-09 17:22:00
Documents
1
Period of Report
2022-08-08

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2222999-4_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2222999-4_4seq1.xml 4 3113
  Complete submission text file 0001104659-22-088034.txt   4614
Mailing Address 501 FIFTH STREET BRISTOL TN 37620
Business Address
MARKISON BRIAN A (Reporting) CIK: 0001283061 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38709 | Film No.: 221149523

Mailing Address 400 CROSSING BOULEVARD BRIDGEWATER NJ 08807
Business Address 400 CROSSING BOULEVARD BRIDGEWATER NJ 08807 9088091300
RVL Pharmaceuticals plc (Issuer) CIK: 0001739426 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations